Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Cochlear Limited (ASX: COH) - Share Price and Research
- Current share price for COH : $314.770
Cochlear Limited (COH), an ASX-listed company, is a manufacturer and distributor of cochlear implantable devices for hearing impaired. Cochlear have operations in over 30 countries distributing its products in America, Asia Pacific and Europe.
COH General Information +
| ASX Code | COH |
| Website | http://www.cochlear.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 20,615 |
| COH Share Price | $314.770 |
| Day High | $317.760 |
| Day Low | $313.000 |
| Last Close | $314.770 |
| COH Share Price Movement | - ( No change ) |
Prices as at 16:40, 16 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
Recommendation
Cochlear Limited - COH
BUY
below 
HOLD
up to
SELL
above
Current price
$314.77 at 16:40 (16 April 2024)
Price at review
$329.15 at (20 February 2024)
Max Portfolio Weighting
Business Risk
Share Price Risk
All Prices are in AUD ($)
COH Related Research
Cochlear Limited (COH) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | $2.00 | 70% | 21 Mar 2024 | 15 Apr 2024 | $314.770 | $319.070 | 1.18% |
| HFResult | $1.75 | 70% | 18 Sep 2023 | 11 Oct 2023 | $314.770 | $319.070 | 1.18% |
| Result | $1.55 | 35% | 21 Mar 2023 | 14 Apr 2023 | $314.770 | $319.070 | 1.18% |
See all dividends from Cochlear Limited (COH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Cochlear Limited (COH) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Notification of cessation of securities - COH | 5 Apr 2024 9:36AM | $333.590 | $314.770 | $319.070 | fallen by 5.64% |
| AXX: ACCC will not oppose revised Cochlear, Oticon transacti | 4 Apr 2024 9:08AM | $329.930 | $314.770 | $319.070 | fallen by 4.59% |
| Appendix 3Z - Yasmin Allen | 2 Apr 2024 9:13AM | $337.520 | $314.770 | $319.070 | fallen by 6.74% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Cochlear Limited (COH) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
COH Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025F | $435.94 | $661.38 | 11.10% | 47.59 | 460.00 | 1.46% | 100.0% |
| 2024F | $392.52 | $595.51 | 28.60% | 52.86 | 420.00 | 1.33% | 100.0% |
| 2023A | $305.20 | $463.15 | 10.00% | 47.25 | 330.00 | 1.51% | 53.6% |
COH Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 F | 2025 F | 2023 A | 2024 F | 2025 F | 2023 A | 2024 F | 2025 F | ||
| Cochlear (COH) | $20,852M | 0.1063 | 0.3407 | 0.1157 | 68.7527 | 51.2821 | 45.9628 | 1.04% | 1.32% | 1.52% |
| Fisher & Paykel Hlth (FPH) | $14,214M | -0.3337 | 0.0147 | 0.3119 | 60.4720 | 59.5984 | 45.4274 | 1.67% | 1.34% | 1.49% |
| ResMed (RMD) | $17,874M | 0.1879 | 0.0958 | 0.1089 | 31.2154 | 28.4852 | 25.6870 | 0.71% | 0.96% | 1.06% |
COH Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 1.57 | 53.50 | 11.80 | 2.40 |
| Market | 0.64 | 16.40 | 1.38 | 1.28 |
| Sector | 0.86 | 32.50 | 2.34 | 2.40 |
COH Directors
| Name | Position | Start Date |
|---|---|---|
| Ms Christine Frances McLoughlin | Non-Executive Director | 1 Nov 2020 |
| Mr Michael Grenfell Daniell | Non-Executive Director | 1 Jan 2020 |
| Ms Karen Lee Collett Penrose | Non-Executive Director | 1 Jul 2022 |
| Mr Glen Francis Boreham | Non-Executive Director | 1 Jan 2015 |
| Professor Bruce Gregory Robinson | Non-Executive Director | 13 Dec 2016 |
| Mr Michael del Prado | Non-Executive Director | 1 Jan 2022 |
| Ms Catriona Alison Deans | Non-Executive Director, Non-Executive Chairman | 1 Jan 2015 |
| Mr Dig Howitt | President, Chief Executive Officer, Managing Director | 14 Nov 2017 |
Cochlear Limited (COH) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 12 Mar 2024 | HOWITT, Dig | Buy | Direct Shares | 279 | $217.280 | $60,621.120 |
| 12 Mar 2024 | HOWITT, Dig | Exercise | Options | 279 | $217.280 | $60,621.120 |
| 14 Nov 2023 | DEL PRADO, Michael | Buy | Direct Shares | 117 | $169.220 | $19,798.740 |
See all changes in directors' interest & trades for Cochlear Limited (COH) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
COH Management
| Name | Position |
|---|---|
| Ray Jarman | Company Secretary |
COH Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Cochlear Limited (COH). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 4,477,869 (6.82%) | BlackRock Group |
| 3,863,824 (5.88%) | State Street Corporation and subsidiaries |
| 3,541,229 (5.39%) | Algemen Burgerlijk PSF |
| 3,299,003 (5.02%) | Pinnacle Investment Management Group Limited |
COH Calendar of Events
| Date | Event |
|---|---|
| 17 February 2025 | Report (Interim) |
| 13 August 2024 | Report (Annual) |
| 13 August 2024 | Report (Prelim) |
FAQs about Cochlear Limited (COH)
What is the current share price of Cochlear Limited (COH)?
Cochlear Limited's (COH) current share price is $314.77. This constitutes a price movement of 1.35% when compared to the share price 7 days ago and is -10.11% below COH's 12-month high of $350.17 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Cochlear Limited (COH)?
Relative to the previous close share price of $314.77, Cochlear Limited's (COH) current share price of $314.77 constitutes a movement of or 0%. Cochlear Limited's (COH) share price movement is -1.35% when compared to 7 days ago and is -10.11% below COH's 52-week high of $350.17.
What is the 52-week high share price for Cochlear Limited (COH)?
Cochlear Limited's (COH) 52-week high is $350.17 which was reached on 29 Feb 2024. Relative to this, COH's current share price of $314.77 constitutes a -$35.40 or -10.11% drop since that high of $350.17 per COH share.
What is the 52-week low share price for Cochlear Limited (COH)?
Cochlear Limited's (COH) 52-week low is $221.56 which was reached on 7 Jul 2023. Relative to this, COH's current share price of $314.77 constitutes a $93.21 or 42.07% gain since that low of $221.56 per COH share.
What is the daily average trading volume for Cochlear Limited (COH)?
Over the last 12 months, Cochlear Limited (COH) has a daily average trading volume of 145,221 COH shares per day.
What is the dividend yield for Cochlear Limited (COH)?
Cochlear Limited (COH) has a current dividend yield of n/a this year. Last year's dividend yield was 1.40%. The dividend yield for COH is a ratio that tells you the percentage of Cochlear Limited's (COH) share price that it pays out in dividends each year.
What was Cochlear Limited (COH) last dividend payment?
Cochlear Limited (COH) last dividend payment was $2.00 per share and was paid on 15 Apr 2024. This last COH dividend included 70% franking.
What is the franking level for Cochlear Limited (COH)?
Cochlear Limited (COH) has a franking level of 100%. Franking represents the tax Cochlear Limited (COH) has already paid on any profit it distributes to shareholders as a dividend.
When does Cochlear Limited (COH) release its next Annual Report?
Cochlear Limited (COH) will release its next Annual Report on 13 August 2024. Cochlear Limited's (COH) last annual report was released on 15 Aug 2023. Click here to view Cochlear Limited's (COH) last annual report.
In which sector is Cochlear Limited (COH) classified?
Cochlear Limited (COH) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Fisher & Paykel Healthcare Corporation Limited (FPH), and Sonic Healthcare Limited (SHL).
What is the price-to-earnings (P/E) ratio for Cochlear Limited (COH)?
The price-to-earnings (P/E) ratio for Cochlear Limited (COH) is 53.5. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Cochlear Limited's (COH) share price to its earnings per COH share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
